ArticleTranslational cancer research2019

An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progression: the association with

Hsiang-Lin Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.